BGXX logo

Bright Green (BGXX)

Profile

Full Name

Bright Green Corporation

Ticker Symbol

BGXX

Exchange

NASDAQ

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Country

United States

IPO

May 17, 2022

Indexes

Not included

Website

http://www.brightgreen.us

Employees

5

Key Details

Price

$0.04(0.00%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

-

Annual EPS

-$0.07(+58.82% YoY)

PE ratio

-

Next earnings date

May 20, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$0.04
BGXX price is $0.04

30-Day Relative Volume

0.00
BGXX 30-day relative volume is 0.00

Price Performance

Price Most recent change

0%
BGXX {parameterFullLabel} has remained unchanged on Apr 16, 2025

Price YTD change

-26.92%
BGXX price is down -26.92% since January 1st

Price 1-year change

-82.57%
BGXX price is down -82.57% year-on-year

Price 3-year change

-
BGXX price 3-year change is unknown

Price Range

Price All-time high

$58.00
BGXX price is currently -99.93% below its historical high of $58.00

Price 3-year low

$0.03
BGXX price is currently +26.67% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$7.26M
BGXX market capitalization is $7.26 million

Market cap 3-year change

-
BGXX market capitalization 3-year change is unknown

Market cap All-time high

$7.61B
BGXX market capitalization is currently -99.90% below its historical high of $7.61 billion

Market cap sector rank

16.61%
BGXX market capitalization is higher than 16.61% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+20.72%
BGXX shares outstanding is up +20.72% year-on-year

Shares Outstanding 3-Year Change

-
BGXX shares outstanding 3-year change is unknown

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

0.44
BGXX beta is 0.44

200-day SMA

$0.11
BGXX price is currently -66.49% below its 200-day simple moving average

50-day SMA

$0.04
BGXX price is currently -1.55% below its 50-day simple moving average

RSI

50.00
BGXX 14-day relative strength index is 50.00

Volume

0.00
BGXX 30-day relative volume is 0.00

ATR

$0.00
BGXX average true range is $0.00

10-day Historical Volatility

0.00%
BGXX 10-day historical volatility is 0.00%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

-
BGXX annual revenue value is unknown

Revenue Analysts estimate

-
BGXX annual revenue consensus analysts' forecast is unknown

Revenue 1-year change

-
BGXX annual revenue 1-year change is unknown

Revenue Sector rank

-
BGXX annual revenue is unknown

EPS

EPS

-$0.07
BGXX annual earnings per share is -$0.07

EPS Analysts estimate

-
BGXX annual earnings per share consensus analysts' forecast is unknown

EPS 1-year change

+58.82%
BGXX annual earnings per share is up +58.82% year-on-year

EPS Sector rank

81.16%
BGXX annual earnings per share is higher than 81.16% of companies in Healthcare sector

Profit

Gross profit

-
BGXX annual gross profit value is unknown

Gross margin

-
BGXX annual gross profit margin value is unknown

Operating profit

-$8.89M
BGXX annual operating income is -$8.89 million

Operating margin

-
BGXX annual operating profit margin value is unknown

Net income

-$13.13M
BGXX annual net profit is -$13.13 million

Net margin

-
BGXX annual net profit margin value is unknown

Expenses

Total expenses

$8.89M
BGXX annual total expenses is $8.89 million

Operating expenses

$8.89M
BGXX annual total operating expenses is $8.89 million

Cost of goods sold

-
BGXX annual cost of goods sold value is unknown

Selling, general & administrative expenses

$8.20M
BGXX annual SGA is $8.20 million

Depreciation and amortization

$638.50K
BGXX annual depreciation & amortization is $638.50 thousand

Interest expense

-
BGXX annual interest expense value is unknown

Income tax

$0.00
BGXX annual income tax is $0.00

EBIT & EBITDA

EBIT

-$8.89M
BGXX annual earnings before interest & taxes is -$8.89 million

EBITDA

-$8.25M
BGXX annual EBITDA is -$8.25 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$17.40M
BGXX annual total assets is $17.40 million

Non current assets

$17.13M
BGXX annual long term assets is $17.13 million

Current assets

$268.30K
BGXX annual total current assets is $268.30 thousand

Cash and cash equivalents

$10.10K
BGXX annual cash & cash equivalents is $10.10 thousand

Accounts receivable

-
BGXX annual accounts receivable value is unknown

Inventory

-
BGXX annual inventory value is unknown

Liabilities

Total liabilities

$6.44M
BGXX annual total liabilities is $6.44 million

Long term liabilities

$201.80K
BGXX annual total long term liabilities is $201.80 thousand

Current liabilities

$6.24M
BGXX annual total current liabilities is $6.24 million

Accounts payable

$4.18M
BGXX annual accounts payable is $4.18 million

Debt

Total debt

$1.85M
BGXX annual total debt is $1.85 million

Total debt 1-year change

-67.67%
BGXX annual total debt is down -67.67% year-on-year

Long term debt

$201.80K
BGXX annual long term debt is $201.80 thousand

Short term debt

$1.65M
BGXX annual short term debt is $1.65 million

Equity & Capital

Shareholders equity

$10.96M
BGXX annual stockholders equity is $10.96 million

Book value

$10.96M
BGXX annual book value is $10.96 million

Retained earnings

-$47.20M
BGXX annual retained earnings is -$47.20 million

Working capital

-$5.97M
BGXX annual working capital is -$5.97 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$2.46M
BGXX annual cash flow from operations is -$2.46 million

Cash from operations 1-year change

-8.38%
BGXX annual cash flow from operations is down -8.38% year-on-year

Cash from investing

-$2.53M
BGXX annual cash flow from investing activities is -$2.53 million

Cash from investing 1-year change

+82.37%
BGXX annual cash flow from investing activities is up +82.37% year-on-year

Cash from financing

$4.58M
BGXX annual cash flow from financing activities is $4.58 million

Cash from financing 1-year change

-70.92%
BGXX annual cash flow from financing activities is down -70.92% year-on-year

CAPEX

CAPEX

-
BGXX annual capital expenditures value is unknown

CAPEX 1-year change

-
BGXX annual capital expenditures 1-year change is unknown

Free Cash Flow

Free cash flow

-$4.99M
BGXX annual free cash flow is -$4.99 million

Free cash flow 1-year change

+60.98%
BGXX annual free cash flow is up +60.98% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

-
BGXX annual gross profit margin value is unknown

Operating margin

-
BGXX annual operating profit margin value is unknown

Net margin

-
BGXX annual net profit margin value is unknown

ROA & ROE

ROA

-75.43%
BGXX annual return on assets is -75.43%

ROE

-119.72%
BGXX annual return on equity is -119.72%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
BGXX price to earnings ratio value is unknown

PE ratio Sector rank

-
BGXX price to earnings ratio is unknown

PB Ratio

PB ratio

0.74
BGXX price to book ratio is 0.74

PB ratio Sector rank

38.06%
BGXX price to book ratio is higher than 38.06% of companies in Healthcare sector

PS Ratio

PS ratio

-
BGXX price to sales ratio value is unknown

PS ratio Sector rank

-
BGXX price to sales ratio is unknown

Enterprise value

Enterprise value

$7.68M
BGXX enterprise value is $7.68 million

Enterprise value Sector rank

22.05%
BGXX enterprise value is higher than 22.05% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-1.26
BGXX EV/EBITDA is -1.26

EV/EBITDA Sector rank

39.57%
BGXX EV/EBITDA is higher than 39.57% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

0.04
BGXX annual current ratio is 0.04

Quick ratio

-
BGXX annual quick ratio value is unknown

Leverage

Debt to equity

0.17
BGXX annual debt to equity ratio is 0.17

Interest coverage ratio

-
BGXX annual interest coverage ratio value is unknown

Risk & Stability

Piotroski F-Score

-
BGXX piotroski f-score value is unknown

Altman Z-Score

-
BGXX altman z-score value is unknown

Analyst ratings

Recent major analysts updates

No data about analysts updates

Institutional Ownership

Similar stocks

CHRO logo
Channel Therapeutics (CHRO)
Dogwood Therapeutics (DWTX)
BFRI logo
Biofrontera (BFRI)
MYNZ logo
Mainz Biomed BV (MYNZ)
CDT logo
Conduit Pharmaceuticals (CDT)
CANF logo
Can-Fite BioPharma (CANF)
WORK Medical Technology Group LTD (WOK)
INDP logo
Indaptus Therapeutics (INDP)
BMRA logo
Biomerica (BMRA)
  • What is the ticker symbol for Bright Green?
  • Does Bright Green pay dividends?
  • What sector is Bright Green in?
  • What industry is Bright Green in?
  • What country is Bright Green based in?
  • When did Bright Green go public?
  • Is Bright Green in the S&P 500?
  • Is Bright Green in the NASDAQ 100?
  • Is Bright Green in the Dow Jones?
  • When was Bright Green's last earnings report?
  • When does Bright Green report earnings?

What is the ticker symbol for Bright Green?

The ticker symbol for Bright Green is NASDAQ:BGXX

Does Bright Green pay dividends?

No, Bright Green does not pay dividends

What sector is Bright Green in?

Bright Green is in the Healthcare sector

What industry is Bright Green in?

Bright Green is in the Drug Manufacturers - Specialty & Generic industry

What country is Bright Green based in?

Bright Green is headquartered in United States

When did Bright Green go public?

Bright Green's initial public offering (IPO) was on May 17, 2022

Is Bright Green in the S&P 500?

No, Bright Green is not included in the S&P 500 index

Is Bright Green in the NASDAQ 100?

No, Bright Green is not included in the NASDAQ 100 index

Is Bright Green in the Dow Jones?

No, Bright Green is not included in the Dow Jones index

When was Bright Green's last earnings report?

Bright Green's most recent earnings report was on Nov 19, 2024

When does Bright Green report earnings?

The next expected earnings date for Bright Green is May 20, 2025
On this page